|
Name
|
Auflagedatum
|
Volumen
|
YTD-P
|
1-Y-P
|
3-Y-P
|
5-Y-P
|
|
HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund
LU1540961759
USD / Acc. / Retail
|
30.12.2011
14,7 Jahre
|
16,41 |
+13,56% |
+41,06% |
+63,63% |
+32,10% |
|
Polar Capital Funds PLC - Biotechnology Fund
IE00B42Z4531
USD / Dist. / Retail
|
31.10.2013
12,9 Jahre
|
3.652,27 |
+23,25% |
+54,17% |
+101,21% |
+88,31% |
|
Invesco NASDAQ Biotech UCITS ETF
IE00BQ70R696
USD / Acc. / Retail
|
06.11.2014
11,9 Jahre
|
429,77 |
+26,39% |
+53,76% |
+63,51% |
+38,04% |
|
Protea Fund - Sectoral Biotech Opportunities Fund
LU1176840327
USD / Acc. / Retail
|
27.02.2015
11,6 Jahre
|
27,08 |
+11,08% |
+39,76% |
+38,28% |
+11,65% |
|
PPF ("PMG Partners Funds") - Helix Biotechnology Fund
LU1230343250
USD / Acc. / Retail
|
21.10.2015
10,9 Jahre
|
37,35 |
+30,36% |
+71,16% |
+60,19% |
+2,37% |
|
Aescap Life Sciences
NL0012343958
EUR / Acc. / Retail
|
29.03.2016
10,5 Jahre
|
137,38 |
+7,62% |
+53,36% |
+66,76% |
+22,11% |
|
iShares Nasdaq US Biotechnology UCITS ETF
IE00BYXG2H39
USD / Acc. / Retail
|
19.10.2017
8,9 Jahre
|
1.097,26 |
+26,26% |
+53,52% |
+63,31% |
+37,82% |
|
L&G Pharma Breakthrough UCITS ETF
IE00BF0H7608
USD / Acc. / Retail
|
18.01.2018
8,7 Jahre
|
21,23 |
+15,24% |
+31,56% |
+33,40% |
+18,93% |
|
Janus Henderson Horizon Biotechnology Fund
LU1897414303
USD / Acc. / Retail
|
10.12.2018
7,8 Jahre
|
1.918,06 |
+20,72% |
+66,91% |
+93,80% |
+110,38% |
|
JPMorgan Funds - Thematics - Genetic Therapies Fund
LU2050612402
USD / Acc. / Retail
|
24.10.2019
6,9 Jahre
|
354,06 |
+21,09% |
+47,92% |
+25,24% |
-22,34% |